PMID: 7019349Jan 1, 1981Paper

Specific and nonspecific immune resistance enhancing activity of staphage lysate

Journal of Immunopharmacology
H J EsberA E Bogden

Abstract

The immunopotentiating activity of staphage lysate (SPL) was evaluated in terms of its immune protection against lethal bacterial infection and its antitumor activity. Mice were pretreated weekly with 10(8) viable, Staphylococcus aureus, strain 18Z for 3 weeks (Induction), followed by intraperitoneal SPL injections (Elicitation) at various times in relation to infectious challenge or tumor implantation. Induction without elicitation, or elicitation alone failed to provide protection against Klebsiella pneumoniae infection and resulted in only 30-40% survival against homologous infection with pathogenic S. aureus type III, whereas combined induction and elicitation produced enhanced resistance induction and elicitation regimens resulted in 50% and 80-100% survival in mice inoculated with K. pneumoniae and S. aureus, respectively. SPL had no antitumor effect in mice implanted with median survival time resulting from induction and elicitation in animals implanted which Ehrlich's ascites. This enhancement of immune resistance may possibly be related to activation of thymus-modulated lymphocytes and macrophages by SPL.

Citations

Oct 1, 1985·Immunopharmacology·H J EsberH Rosenkrantz
Aug 1, 1997·Seminars in Veterinary Medicine and Surgery (small Animal)·K R Van Kampen
Jan 1, 1988·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·A MathurJ W Futrell
Jul 1, 1994·Human & Experimental Toxicology·K LindeF Eitel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.